Isabel Cano

482 total citations
21 papers, 154 citations indexed

About

Isabel Cano is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Isabel Cano has authored 21 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Isabel Cano's work include Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Neutropenia and Cancer Infections (4 papers). Isabel Cano is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Neutropenia and Cancer Infections (4 papers). Isabel Cano collaborates with scholars based in Spain, United States and United Kingdom. Isabel Cano's co-authors include Miguel Á. Sanz, Federico Moscardó, Pau Montesinos, Pilar Solves, Nelly Carpio, Rebeca Rodríguez‐Veiga, David Martínez‐Cuadrón, F. Hernández‐Navarro, Ignacio Lorenzo and Marcos Arango and has published in prestigious journals such as Blood, Cancers and Biology of Blood and Marrow Transplantation.

In The Last Decade

Isabel Cano

21 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabel Cano Spain	8	80	45	43	43	27	21	154
Livia Giannoni Italy	8	75 0.9×	61 1.4×	24 0.6×	20 0.5×	24 0.9×	18	146
Vincenzo Cassibba Italy	6	77 1.0×	56 1.2×	37 0.9×	36 0.8×	43 1.6×	12	190
Madhuri Vusirikala United States	7	129 1.6×	32 0.7×	55 1.3×	48 1.1×	16 0.6×	28	191
Uroš Markovic Italy	8	95 1.2×	41 0.9×	60 1.4×	33 0.8×	24 0.9×	36	188
Clémence Mediavilla France	8	88 1.1×	31 0.7×	26 0.6×	31 0.7×	27 1.0×	18	137
Machiko Kusuda Japan	8	82 1.0×	56 1.2×	13 0.3×	22 0.5×	37 1.4×	38	152
Jennifer Kaivers Germany	7	132 1.6×	27 0.6×	39 0.9×	42 1.0×	13 0.5×	22	172
Martin Andres Switzerland	6	45 0.6×	30 0.7×	32 0.7×	37 0.9×	12 0.4×	15	131
Nadira Duraković Croatia	9	132 1.6×	37 0.8×	40 0.9×	66 1.5×	42 1.6×	34	261
Alessandro Bonini Italy	6	88 1.1×	23 0.5×	31 0.7×	29 0.7×	24 0.9×	12	142

Countries citing papers authored by Isabel Cano

Since Specialization

Citations

This map shows the geographic impact of Isabel Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Cano more than expected).

Fields of papers citing papers by Isabel Cano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Cano. The network helps show where Isabel Cano may publish in the future.

Co-authorship network of co-authors of Isabel Cano

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Cano. A scholar is included among the top collaborators of Isabel Cano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Cano. Isabel Cano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salamero, Olga, Josè Antonio Pérez-Simón, Montserrat Arnán, et al.. (2024). Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study. The Lancet Haematology. 11(7). e487–e498. 9 indexed citations

Megías‐Vericat, Juan Eduardo, Blanca Boluda, Isabel Cano, et al.. (2022). Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study. Cancers. 14(8). 1921–1921. 2 indexed citations

Martínez‐López, Joaquín, Pau Montesinos, Rosa Ayala, et al.. (2022). Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia. PubMed. 2(2). 7–7. 2 indexed citations

Salamero, Olga, Tim C. P. Somervaille, Josè Antonio Pérez-Simón, et al.. (2022). Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial. Blood. 140(Supplement 1). 1711–1713. 7 indexed citations

Boluda, Blanca, Rebeca Rodríguez‐Veiga, Isabel Cano, et al.. (2021). Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain. European Journal Of Haematology. 106(5). 724–733. 1 indexed citations

Saiz‐Rodríguez, Miriam, Jorge Labrador, Beatriz Cuevas, et al.. (2021). Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis. Cancers. 13(22). 5677–5677. 9 indexed citations

Boluda, Blanca, Isabel Cano, Rebeca Rodríguez‐Veiga, et al.. (2021). Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain. Journal of Clinical Apheresis. 36(4). 612–620. 5 indexed citations

Megías‐Vericat, Juan Eduardo, David Martínez‐Cuadrón, María José Herrero, et al.. (2021). Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia. Pharmacogenetics and Genomics. 31(6). 133–139. 4 indexed citations

Ribera, Josep‐María, Olga García, Jordi Ribera, et al.. (2021). Ponatinib and Chemotherapy in Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Final Results of Ponalfil Clinical Trial. Blood. 138(Supplement 1). 1230–1230. 4 indexed citations

10.

Salamero, Olga, Tim C. P. Somervaille, Josè Antonio Pérez-Simón, et al.. (2021). Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial). Blood. 138(Supplement 1). 3376–3376. 3 indexed citations

11.

Megías‐Vericat, Juan Eduardo, David Martínez‐Cuadrón, María José Herrero, et al.. (2020). Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Leukemia & lymphoma. 62(3). 659–668. 9 indexed citations

12.

Salamero, Olga, Tim C. P. Somervaille, Isabel Cano, et al.. (2020). Robust Efficacy Signals in Elderly AML Patients Treated with Iadademstat in Combination with Azacitidine (ALICE Phase IIa Trial). Blood. 136(Supplement 1). 22–22. 3 indexed citations

13.

Sanz, Jaime, Isabel Cano, Eva M. González‐Barberá, et al.. (2015). Bloodstream Infections in Adult Patients Undergoing Cord Blood Transplantation from Unrelated Donors after Myeloablative Conditioning Regimen. Biology of Blood and Marrow Transplantation. 21(4). 755–760. 26 indexed citations

14.

Montesinos, Pau, Rebeca Rodríguez‐Veiga, David Martínez‐Cuadrón, et al.. (2015). Treatment of invasive fungal disease using anidulafungin alone or in combination for hematologic patients with concomitant hepatic or renal impairment. Revista Iberoamericana de Micología. 32(3). 185–189. 5 indexed citations

15.

Megías‐Vericat, Juan Eduardo, Pau Montesinos, María José Herrero, et al.. (2015). Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia. Blood. 126(23). 4845–4845. 1 indexed citations

16.

Solves, Pilar, et al.. (2015). Passenger lymphocyte syndrome in liver transplant recipients: a description of 12 cases.. PubMed. 13(3). 423–8. 15 indexed citations

17.

Megías‐Vericat, Juan Eduardo, Pau Montesinos, María José Herrero, et al.. (2015). Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia. Blood. 126(23). 4842–4842. 2 indexed citations

18.

Megías‐Vericat, Juan Eduardo, Pau Montesinos, María José Herrero, et al.. (2014). Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults. Blood. 124(21). 2237–2237. 1 indexed citations

19.

Solves, Pilar, Nelly Carpio, Federico Moscardó, et al.. (2014). Transfusion Management and Immunohematologic Complications in Liver Transplantation: Experience of a Single Institution. Transfusion Medicine and Hemotherapy. 42(1). 8–14. 13 indexed citations

20.

Cano, Isabel, et al.. (1996). Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Association with morphology and resistance to conventional chemotherapy. Cancer Genetics and Cytogenetics. 90(2). 118–124. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact